Dr. Michael S. Katcher, MD
Cardiology (Cardiovascular Disease Physician)
- Medicare participating
At a glance
- Medical school
- Boston University School of Medicine (1990)
- Years since graduation
- 36
- In the NPI registry since
- 2005
- Medicare patients seen, 2024
- 2,456
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1990Medical school: Boston University School of Medicine
- 2005Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Cardiovascular Disease Physician primary
MA license 76273 -
Clinical Cardiac Electrophysiology Physician
MA license 76273 -
Internal Medicine Physician
MA license 76273
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Massachusetts General Hospital Boston, MA
- North Shore Medical Center - Salem, MA
- Lahey Hospital & Medical Center, Burlington Burlington, MA
- Northeast Hospital Corporation Beverly, MA
- Wentworth-Douglass Hospital Dover, NH
Medical groups
- Mass General Brigham Medical Group Northern Massachusetts Inc (827 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 2,456
- Services billed
- 7,866
- Patients’ average age
- 77
| Service | Times | Patients |
|---|---|---|
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 1,498 | 1,177 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 940 | 311 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 761 | 512 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 633 | 81 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 461 | 160 |
| Programming of dual lead pacemaker system | 394 | 267 |
| Established patient office or other outpatient visit, 40-54 minutes | 357 | 283 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 341 | 125 |
| Established patient office or other outpatient visit, 30-39 minutes | 213 | 191 |
| Evaluation of implantable heart and blood vessel monitoring system | 203 | 134 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Metoprolol Succinate Other prescribers in Salem, MA | 126 |
| Cephalexin Other prescribers in Salem, MA | 77 |
| Eliquis (apixaban) Other prescribers in Salem, MA | 56 |
| Atorvastatin Calcium Other prescribers in Salem, MA | 51 |
| Amiodarone Hcl Other prescribers in Salem, MA | 17 |
| Amlodipine Besylate Other prescribers in Salem, MA | 16 |
| Ezetimibe Other prescribers in Salem, MA | 16 |
| Diltiazem 24hr Er (Cd) (diltiazem hcl) Other prescribers in Salem, MA | 15 |
| Rosuvastatin Calcium Other prescribers in Salem, MA | 12 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 3 companies reported 8 payments worth $10,293 in total to this clinician.
| Abbott Laboratories | $10,253 |
|---|---|
| Boston Scientific Corporation | $20.80 |
| Biotronik Inc. | $19.79 |
| Consulting Fee | $10,118 |
|---|---|
| Food and Beverage | $176 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Abbott Laboratories Jul 31, 2025 | Consulting Fee AVEIR · Structural Heart | $7,563 |
| Abbott Laboratories Sep 23, 2025 | Consulting Fee GALLANT · Structural Heart | $1,100 |
| Abbott Laboratories Jul 22, 2025 | Consulting Fee GALLANT · Structural Heart | $825 |
| Abbott Laboratories Mar 4, 2025 | Consulting Fee GALLANT · Structural Heart | $525 |
| Abbott Laboratories Jul 31, 2025 | Consulting Fee AVEIR · Structural Heart | $105 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $1,600 in research payments for these studies, mostly to the institutions running them.
- AtriCure CryoICE Lesions for Persistent and Long-standing Persistent Atrial Fibrillation Treatment
Atricure, Inc. · Active, not recruiting · NCT03732794
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.